Benzinga | Apr 14, 2021 05:00PM EDT

GSK Provides Update On Its Feladilimab And Its Investigational Inducible T Cell Co-Stimulatory Agonist

https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-feladilimab-an-investigational-inducible-t-cell-co-stimulatory-icos-agonist/